EZH2, Proliferation Rate, and Aggressive Tumor Subtypes in Cutaneous Basal Cell Carcinoma

JAMA Oncol. 2016 Jul 1;2(7):962-3. doi: 10.1001/jamaoncol.2016.0021.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / biosynthesis
  • Biomarkers, Tumor / genetics*
  • Carcinoma, Basal Cell / genetics*
  • Carcinoma, Basal Cell / pathology
  • Cell Proliferation / genetics
  • Enhancer of Zeste Homolog 2 Protein / biosynthesis
  • Enhancer of Zeste Homolog 2 Protein / genetics*
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Ki-67 Antigen / biosynthesis
  • Ki-67 Antigen / genetics
  • Male
  • Neoplasm Staging
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / pathology

Substances

  • Biomarkers, Tumor
  • Ki-67 Antigen
  • EZH2 protein, human
  • Enhancer of Zeste Homolog 2 Protein

Associated data

  • ClinicalTrials.gov/NCT02436408